The Change Mariner

FDA Approves First-In-Class Antibiotic

Forbes:

The Food and Drug Administration approved the first antibiotic in a new class since the approval of Pfizer's Zyvox in 2000. Zyvox then represented the first new class in 35 years. The injectable medicine, called daptomycin and sold under the brand-name Cubicin, will be used to treat certain complicated skin and soft-tissue infections that are resistant to methicillin, a currently available drug. More than 600,000 patients suffer from such infections annually. Staphylococcus aureus, the bacteria that causes these illnesses, is resistant to current drugs 60% of the time, according to Lexington, Mass.-based Cubist Pharmaceuticals, which is selling the drug. Previously, Cubicin was known as Cidecin.

Amazon Price:

Amazon Price: